Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O2VZ
|
||||
| Former ID |
DCL000587
|
||||
| Drug Name |
Otelixizumab
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Company |
GSK
|
||||
| CAS Number |
CAS 881191-44-2
|
||||
| Target and Pathway | |||||
| Target(s) | T-cell surface glycoprotein CD3 | Target Info | Modulator | ||
| References | |||||
| Ref 543149 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8458). | ||||
| Ref 547674 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018350) | ||||